David Liff is a Cardiology physician affiliated with Emory University Hospital. OpenAlex indexes 11 publications with 388 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1436 Broadrick Dr Ste B
Dalton, GA 307203009
Telephone
706-226-3434Provider last certified this registry record 15 Oct 2024.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202519 payments
- Medtronic, Inc.Program year20258 payments
- HEARTFLOW, INC.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
81%Beta blocker20.1%Metoprolol Succinate85%Carvedilol15%Part D≥89 patientsStatin19.5%Atorvastatin Calcium88%Rosuvastatin Calcium12%Part D≥95 patients+ 9 more classes in this area
Blood & clotting
11%Factor Xa inhibitor6.4%Eliquis80%Xarelto21%Part D<11 patientsP2Y12 inhibitor3.2%Clopidogrel70%Brilinta30%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
8%SGLT2 inhibitor4.8%Farxiga100%Part D≥20 patientsGLP-1 receptor agonist3.2%Ozempic100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-term Outcomes After Percutaneous Patent Foramen Ovale Closure
The American Journal of the Medical Sciences
2013 - Repair of Prosthetic Mitral Valve Paravalvular Leak Using an Off-Pump Transapical Approach
The Annals of Thoracic Surgery
2012 - LONG TERM OUTCOMES AFTER PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE
Journal of the American College of Cardiology
2011 - Transcatheter aortic valve replacement: the changing paradigm of aortic stenosis treatment
Expert Review of Cardiovascular Therapy
2011
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”